GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » EV-to-FCF

GALDY (Galderma Group AG) EV-to-FCF : (As of Jan. 18, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Galderma Group AG's Enterprise Value is $30,900 Mil. Galderma Group AG does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024. Therefore, GuruFocus does not calculate Galderma Group AG's EV-to-FCF at this moment.

The historical rank and industry rank for Galderma Group AG's EV-to-FCF or its related term are showing as below:

GALDY' s EV-to-FCF Range Over the Past 10 Years
Min: -748.84   Med: 0   Max: 0
Current: -748.84
GALDY's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.77 vs GALDY: -748.84

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-18), Galderma Group AG's stock price is $24.19. Galderma Group AG does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024. Therefore, GuruFocus does not calculate Galderma Group AG's PE Ratio (TTM) at this moment.

Galderma Group AG EV-to-FCF Historical Data

The historical data trend for Galderma Group AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG EV-to-FCF Chart

Galderma Group AG Annual Data
Trend
EV-to-FCF

Galderma Group AG Semi-Annual Data
Jun23 Jun24
EV-to-FCF - -

Competitive Comparison of Galderma Group AG's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's EV-to-FCF falls into.


Galderma Group AG EV-to-FCF Calculation

Galderma Group AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=30899.607/
=

Galderma Group AG  (OTCPK:GALDY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Galderma Group AG's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=24.19/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Galderma Group AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » EV-to-FCF
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XTAE:TEVA NSE:DIVISLAB VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257
Traded in Other Exchanges
GDERF:USA GALDz:UK GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.